Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18384155rdf:typepubmed:Citationlld:pubmed
pubmed-article:18384155lifeskim:mentionsumls-concept:C0031336lld:lifeskim
pubmed-article:18384155lifeskim:mentionsumls-concept:C0013058lld:lifeskim
pubmed-article:18384155lifeskim:mentionsumls-concept:C1322815lld:lifeskim
pubmed-article:18384155lifeskim:mentionsumls-concept:C1879746lld:lifeskim
pubmed-article:18384155lifeskim:mentionsumls-concept:C1547011lld:lifeskim
pubmed-article:18384155lifeskim:mentionsumls-concept:C1553890lld:lifeskim
pubmed-article:18384155pubmed:issue12lld:pubmed
pubmed-article:18384155pubmed:dateCreated2008-11-6lld:pubmed
pubmed-article:18384155pubmed:abstractTextThis review focuses on the pharmaceutical aspects of the development of drug eluting stents. It discusses the different processes that can be used to obtain a controlled release of a drug from the stent as well as the coatings therefore applied. Results obtained for stents already available on the market or in a far stage of development are discussed. In a final part possible future research areas as well as expected new evolutions in the design of drug eluting stents are presented.lld:pubmed
pubmed-article:18384155pubmed:languageenglld:pubmed
pubmed-article:18384155pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18384155pubmed:citationSubsetIMlld:pubmed
pubmed-article:18384155pubmed:statusMEDLINElld:pubmed
pubmed-article:18384155pubmed:monthDeclld:pubmed
pubmed-article:18384155pubmed:issn1520-6017lld:pubmed
pubmed-article:18384155pubmed:authorpubmed-author:SohierJJlld:pubmed
pubmed-article:18384155pubmed:authorpubmed-author:DeconinckEElld:pubmed
pubmed-article:18384155pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:18384155pubmed:authorpubmed-author:Van den...lld:pubmed
pubmed-article:18384155pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18384155pubmed:volume97lld:pubmed
pubmed-article:18384155pubmed:ownerNLMlld:pubmed
pubmed-article:18384155pubmed:authorsCompleteYlld:pubmed
pubmed-article:18384155pubmed:pagination5047-60lld:pubmed
pubmed-article:18384155pubmed:meshHeadingpubmed-meshheading:18384155...lld:pubmed
pubmed-article:18384155pubmed:meshHeadingpubmed-meshheading:18384155...lld:pubmed
pubmed-article:18384155pubmed:meshHeadingpubmed-meshheading:18384155...lld:pubmed
pubmed-article:18384155pubmed:meshHeadingpubmed-meshheading:18384155...lld:pubmed
pubmed-article:18384155pubmed:year2008lld:pubmed
pubmed-article:18384155pubmed:articleTitlePharmaceutical aspects of drug eluting stents.lld:pubmed
pubmed-article:18384155pubmed:affiliationZiscoat N.V., Interleuvenlaan 62 Zone 2, B-3001 Heverlee, Belgium.lld:pubmed
pubmed-article:18384155pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18384155pubmed:publicationTypeReviewlld:pubmed